Purchase Order 75N94018P00552

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Illumina, Inc. on June 28, 2018, for $14,026.27, with ultimate completion on August 23, 2018. The order covers service agreement support for CBOT and HiSeq sequencers at the agency's Bethesda, Maryland facility. Pricing is firm fixed.</p>

The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Illumina, Inc. for $17,012.48 on April 22, 2019. The order carries a firm fixed price structure and ultimate completion date of April 21, 2020. Performance takes place in San Diego, California. The purchase order procures sequencing instruments, reagents, consumables, or bioinformatics software from Illumina's portfolio—the specific line items are not itemized in the source. No set-aside was used.

<p>The National Institute of Diabetes and Digestive and Kidney Diseases issued a $68,878.59 delivery order to Illumina, Inc. on September 27, 2018, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is Bethesda, MD. The order has a firm fixed-price structure with an ultimate completion date of December 31, 2018. No set-aside was used.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Illumina, Inc. for $66,000 on December 30, 2019, for service on a HiSeq 3000 instrument supporting the NIDDK Genomics Core. Work is performed in San Diego, California. The order carries firm fixed price terms and an ultimate completion date of December 29, 2020. The originating pre-solicitation was posted November 15, 2019, with a proposal due date of November 25, 2019.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Illumina, Inc. valued at $7,882.56 on March 29, 2016. The order is firm fixed price with no set-aside designation. Place of performance is San Diego, California. The order expired on April 24, 2016. No further details regarding the specific items or services procured are provided in the source material.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Illumina, Inc. for $19,011.59 on September 15, 2016, for the supply of genetic analysis products. The order, which carried no set-aside designation, expires on September 30, 2016. Work is performed in Bethesda, Maryland. The procurement is firm fixed price.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases issued a $37,343.66 delivery order to Illumina, Inc. on July 10, 2026.</p> <p>Place of performance is Bethesda, MD 20892. No set-aside was used for this order. The order is priced on a firm fixed-price basis with an ultimate completion date of July 10, 2026.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases issued a delivery order to Illumina, Inc. on June 30, 2017, with a ceiling value of $14,451.36 for HISEQ 3000/4000 PE equipment.</p> <p>Place of performance is San Diego, CA 92122. The order is priced firm fixed price with an ultimate completion date of September 2, 2020. No set-aside was used.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Illumina, Inc. valued at $17,525.75 on March 2, 2016, for on-site field service engineer labor supporting reinstallation work. The order carries a firm fixed price and concludes January 31, 2021. Work is performed in San Diego, California.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Illumina, Inc. for $78,707.44 on June 16, 2017, for Basic Service Level support with a firm fixed price structure. No set-aside was used. Work is performed in San Diego, California. The period of performance runs from June 23, 2017 through June 22, 2018.</p>